Becker's Healthcare September 25, 2025
Mackenzie Bean

HHS is taking new steps to speed the development and review of new cell and gene therapies in the U.S.

Three things to know:

1. The FDA published three draft guidances Sept. 24 detailing strategies for drugmakers to streamline the development and approval of drug candidates to treat rare diseases that affect a small population of patients.

2. The documents promote the use of innovative clinical trial designs,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, HHS, Pharma / Biotech
STAT+: 9 influencers shaping health information online, for better or worse
Charted: Where measles is surging (again)
Flu Season Is a Stress Test. Our Healthcare System Keeps Failing.
SAMHSA Announces $231M Funding for 988 Suicide and Crisis Lifeline Expansion
Opinion: Our podcast ‘Why Should I Trust You?’ connects MAHA and public health. Here’s what we’ve learned

Share Article